Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Pediatric Procedural Sedation
NCT01519167Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in Procedural sedation (PS), sponsored by Pfizer. Primary endpoint: Number of Subjects Who Had Success in Sedation at 24 hours. Started Oct 2012; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT01519167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519167.